Reviscon is a highly purified, high molecular weight Sodium Hyaluronate, dissolved in physiological saline solution.
All synovial joints naturally contain viscoelastic Sodium Hyaluronate, especially those subject to weight-bearing.

In patients with osteoarthritis, for example, the viscoelasticity of synovial fluid is significantly reduced. This causes mechanical stress on the joint, leading to the breakdown of articular cartilage, which limits mobility and results in considerable pain.
Thanks to its product range, the Reviscon Line helps relieve pain and improve overall mobility: the complex viscosity typical of Hyaluronic Acid provides both viscous and elastic properties that are essential for joint health.

The excellent rheological profile of the Reviscon Line ensures optimal viscosity at rest (up to five times higher than many comparable products on the market), leading to optimal pain reduction thanks to superior dynamic elasticity under high stress.

– Reviscon 20 mg in 2 ml: 3–5 infiltrations for gradual therapy;
– Reviscon Mono 48 mg in 2.4 ml: single infiltration, high performance;
– Reviscon Plus 32 mg in 2 ml: high efficacy with 2–3 infiltrations.

Report an adverse effect